[{"id":"465abcfa-e887-4f1c-be6d-a403409fcc56","acronym":"","url":"https://clinicaltrials.gov/study/NCT02650375","created_at":"2021-01-18T12:54:04.162Z","updated_at":"2024-07-02T16:37:26.348Z","phase":"Phase 1","brief_title":"Study of Metatinib Tromethamine Tablet","source_id_and_acronym":"NCT02650375","lead_sponsor":"Jiangsu Simcere Pharmaceutical Co., Ltd.","biomarkers":" MET","pipe":" | ","alterations":" MET amplification • MET exon 14 mutation","tags":["MET"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e MET amplification • MET exon 14 mutation"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e metatinib tromethamine (BMS-794833)"],"overall_status":"Unknown status","enrollment":" Enrollment 24","initiation":"Initiation: 10/01/2015","start_date":" 10/01/2015","primary_txt":" Primary completion: 10/01/2017","primary_completion_date":" 10/01/2017","study_txt":" Completion: 02/01/2018","study_completion_date":" 02/01/2018","last_update_posted":"2017-01-23"}]